Issue Price: Rs. 228 - Rs. 240 Per Equity Share


Issue Detail:
»» Issue Open: May 09, 2011 - May 12, 2011
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: 5,000,000 Equity Shares of Rs. 10
»» Issue Size: Rs. 114.00 - 120.00 Crore
»» Face Value: Rs. 10 Per Equity Share

Incorporated in 2006, Aanjaneya Lifecare Ltd a leading research based integrated pharmaceutical company with established research, manufacturing & marketing capabilities. Company’s product portfolio includes Bulk Drugs, Finished Dosage Forms, Herbal Medicines, Inhalers, Lozenges and Animal Health.

Aanjaneya has a manufacturing facility in Mahad near Mumbai. This facility provides multi-therapeutic product offerings comprising high-end Alkaloids, Quinine Salts, and Veterinary APIs & Cytotoxic API's.

Company also has a Finished Dosages Facility at Perungut Pune. This facility is for manufacturing various types of dosage forms such as Liquid Syrups, oral tablets, lozenges and Gels in several product categories complying with international standards.

Aanjaneya‘s manufacturing facilities are ISO 9001-2000 and WHO GMP certified. As on March 31st 2010 Aanjaneya had 222 employees.

Company Promoters:
The Promoters of the Company are:
1. Dr. Kannan Kashi Vishwanath;
2. Aasda Life Care Limited (earlier known as Finaventure Capital Limited)

Objects of the Issue:
The object of the issue are to:
1. Setting up of Anti Cancer API Facility at Mahad, Maharashtra;
2. Setting up of cGMP Block for APIs at Mahad, Maharashtra;
3. Setting up of Intermediate API Block at Mahad, Maharashtra;
4. Expansion of existing Research and Development centre at Mahad and Pune, Maharashtra;
5. Setting up of a Quality Control and Quality Assurance Block at Mahad, Maharashtra;
6. Setting up of Product Development Laboratory at Mahad, Maharashtra;
7. Setting up of Stores Building at Mahad, Maharashtra;
8. Meeting the Expenses for Branding and Registration of Products in the International Markets;
9. General Corporate Purposes; and
10. Public Issue Expenses.